FDA approves BMS\' multiplemyeloma combo after it doubles progressionfree survival httpbit.ly2SR01qy pharma cancer bmsnews

FDA approves BMS' #multiplemyeloma combo after it doubles progression-free survival http://bit.ly/2SR01qy  #pharma #cancer @bmsnews

13:00 EST 7 Nov 2018 | Pharmafile

FDA approves BMS' #multiplemyeloma combo after it doubles progression-free survival http://bit.ly/2SR01qy  #pharma #cancer @bmsnews

More From BioPortfolio on "FDA approves BMS' #multiplemyeloma combo after it doubles progression-free survival http://bit.ly/2SR01qy  #pharma #cancer @bmsnews"